581/658US=32 / Biol/Mol
Knudsen S. Breast cancer. In: ___. Cancer diagnostics with DNA microarrays. New Jersey: John Wiley & Sons, 2006. p. 87-96. ISBN 978-0-471-78407-4.

CANCER. DIAGNOSTICO; MICROARRAYS DE DNA; CANCER DE MAMA


582/658US=37 / Câncer
Beuth J. Proteolytic enzymes. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 183-8. ISBN 978-1-5889-0323-0.

CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; ENZIMAS PROTEOLITICAS; EXAMES FARMACOLOGICOS; ESTUDOS EXPERIMENTAIS; ESTUDOS CLINICOS; PLASMOCITOMA; CANCER DE MAMA; CANCER COLORRETAL


583/658US=45 / Urologia
Barthelmes L, Gateley CA. What can we learn from breast cancer?. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 17-25. ISBN 978-1-4051-0752-9.

CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE MAMA. PROGNOSTICO; CANCER DE MAMA. EPIDEMIOLOGIA; CANCER DE MAMA. GENETICA; CANCER DE MAMA. TERAPIA CIRURGICA; CANCER DE MAMA. TRIAGEM


584/658US=47 / Clín/Medica
Assis S, Hilakivi-Clarke L. Timing of dietary estrogenic exposures and breast cancer risk. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 14-35. ISBN 978-1-57331-699-5.

EXPOSICOES ESTROGENICOS DIETETICOS; RISCO DE CANCER DE MAMA; CANCER DE MAMA; ESTROGENIOS; DIETA; TEMPO DE EXPOSICAO


585/658US=47 / Imagem
Verhey LJ, Chuang C, Pirzkall A. Magnetic resonance imaging for IMRT. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 177-86. ISBN 3-540-20511-X.

RADIOTERAPIA DE INTENSIDADE MODULADA; RESSONANCIA MAGNETICA; CANCER DE CABECA E PESCOCO; CANCER DE MAMA; CANCER DE PULMAO; CANCER DE PROSTATA


586/658US=47 / Clín/Medica
Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Candore G, Caruso C, Lio D, Palmeri S. Cytokine gene polymorphisms and breast cancer susceptibility. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 104-9. ISBN 978-1-57331-699-5.

CANCER DE MAMA; POLIMORFISMOS DE CITOCINAS; SUSCETIBILIDADE


587/658US=47 / Clín/Medica
Berrino F, Villarini A, Petris M, Raimondi M, Pasanisi P. Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 110-8. ISBN 978-1-57331-699-5.

CANCER DE MAMA; HORNOMAL; FATORES METABOLICOS; DIETA


588/658US=47 / Clín/Medica
Buck MB, Knabbe C. TGF-Beta signaling in breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 119-26. ISBN 978-1-57331-699-5.

ANTIESTROGENEO; TGF-BETA; CANCER DE MAMA; INIBICAO DO CRESCIMENTO; METASTASE


589/658US=47 / Imagem
Arthur DW, Morris MM, Vicini FA, Dogan N. Breast IMRT. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 371-81. ISBN 3-540-20511-X.

RADIOTERAPIA DE INTENSIDADE MODULADA; CANCER DE MAMA


590/658US=47 / Clín/Medica
Traina A, Agostara B, Marasa L, Calabro M, Zarcone M, Carruba G. HER2/neu expression. in relation to clinicopathologic features of breast câncer patients. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 159-67. ISBN 978-1-57331-699-5.

HER2/NEU; CANCER DE MAMA; ANALISE DE SOBREVIDA GLOBAL


591/658US=47 / Clín/Medica
Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 218-27. ISBN 978-1-57331-699-5.

ESTROGENIO; RECEPTOR DE ESTROGENO; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENO; OSTEOCLASTOS; CELULAS DENDRITICAS; MICROGLIA; MACROFAGOS ASSOCIADOS A TUMORES; CANCER DE MAMA; CANCER DE PROSTATA


592/658US=47 / Clín/Medica
Hong Y, Chen S. Aromatase inhibitors: structural features and biochemical characterization. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 237-51. ISBN 978-1-57331-699-5.

INIBIDORES DA AROMATASE; CANCER DE MAMA; INIBIDORES DE AROMATASE; FLAVONOIDE FITOESTROGENO; INIBIDOR BASEADO NO MECANISMO; MODELO STRCTURAL


593/658US=49-A / Câncer
Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H. Clinical results of vaccine therapy for cancer: learning from history for improving the future. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2006. p. 147-202. ISBN 978-0-12-006695-7.

CANCER; VACINA; RESULTADOS CLINICOS; DOENCAS DE CELULAS B; ENSAIOS DE VACINAS; LEUCEMIA LINFOCITICA CRONICA DE CELULAS B; MIELOMA MULTIPLO; CARCINOMA DE CELULAS RENAIS; CANCER DE PROSTATA; MELANOMA; CANCER GASTROINTESTINAL; CANCER GINECOLOGICO; CANCER DE PULMAO; CANCER DE MAMA


594/658US=55 / Biol/Mol
Kroep JR, Peters GJ, Nagourney RA. Clinical activity of gemcitabine as a single agent and in combination. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 253-88. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

GEMCITABINA; ATIVIDADE CLINICA; CANCER DE MAMA; CISPLATINA; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; CANCER DE OVARIO; CANCER DE PANCREAS; RADIOTERAPIA; TAXANE


595/658US=61 / Câncer
osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO


596/658US=61 / Câncer
Kee K, Green JE. Clinical aspects of resistance: molecular profiling in breast cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 559-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

CANCER DE MAMA; PERFIL DE EXPRESSAO DO GENE; MICROARRAY; ANALISE DA SEQUENCIA DE OLIGONUCLEOTIDO MATRIZ; GENOMICA; ALVOS TERAPEUTICOS


597/658Câncer
Chojniak R, Rosolia C, Figueiredo ZA, Yu LS, Marques E, Costa CL, Bitencourt AGV, Souza JA. Prevalence of anxiety in women undergoing mammography. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 76-9, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.76-9.pdf

ANSIEDADE; CANCER DE MAMA; CANCER SCREENING; DETRECCAO PRECOCE; MAMMOGRAFIA


598/658Câncer
Alberti LR, Lima DCA. A rare case of breast cancer metastasis to the colon: a case report. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 99-100, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.99-100.pdf

CANCER DE MAMA; COLONOSCOPIA; METASTASES NEOPLASICA


599/658US=62 / Biol/Mol
Davis TL, Goldman AJ, Cress AE. Suppression and alteration of adhesion structures in human epitelial cancer progression. In: Cress AE, Nagle RB. Cell adhesion and cytoskeletal molecules in metastasis. New York: Springer, 2006. p. 19-46. (Cancer Metastasis - Biology and Treatment, 9) ISBN 978-1-4020-5128-9.

ADESAO CELULAR; CARCINOMA; MATRIZ EXTRACELULAR; HEMIDESMOSSOMO; CITOQUERATINA; LAMININA; CD151; INTEGRINA; CANCER DE PROSTATA; CANCER DE COLON; CANCER DE MAMA; METASTASE


600/658US=62 / Biol/Mol
Futscher BW, Domann FE. Epigenetic regulation of genes that affect tumor cell adhesion. In: Cress AE, Nagle RB. Cell adhesion and cytoskeletal molecules in metastasis. New York: Springer, 2006. p. 123-40. (Cancer Metastasis - Biology and Treatment, 9) ISBN 978-1-4020-5128-9.

REGULACAO EPIGENETICA DE GENES; ADESAO DE CELULAS TUMORAIS; MASPIN; CANCER EPITELIAL; ILHAS CPG; METILACAO DO DNA; DESACETILACAO DAS HISTONAS; CANCER DE MAMA; CANCER DE PROSTATA; MARCADORES EPIGENETICOS


Primeira | Anterior | Próxima | Última